News On Japan

Revealed: The Reason a Doctor Halted COVID-19 Vaccinations

TOKYO, Jan 28 (News On Japan) - Kunihiko Oishi, anchor for the program "Chanto!", discusses the topic of COVID-19 vaccines. Since October 2024, Japan has introduced routine vaccinations for COVID-19 to prevent severe cases. However, some healthcare professionals have chosen to stop administering the vaccines. One such doctor shared their reasons.

The routine COVID-19 vaccination program, initiated in October 2024, primarily targets the elderly. While initial vaccination rates exceeded 90% for the first two doses in 2021, the eighth round of vaccinations had a participation rate of only 2% as of late October. By the end of December, Nagoya City’s preliminary data showed the rate had risen slightly to 10%, reflecting a significant decline in interest compared to previous rounds.

Nagoya City's data reveals that COVID-19 vaccine uptake stands at 10%, with each medical institution reporting an average of 6.27 COVID-19 patients as of January 22. In contrast, influenza vaccines boast a 45% uptake rate, yet influenza patient numbers are significantly higher, with 16.13 cases per medical institution on the same date. Despite lower vaccination rates, COVID-19 appears to have fewer patients compared to influenza during this period.

At Tsuba Clinic in Takahama City, Aichi Prefecture, the administration of COVID-19 vaccines has ceased. The clinic's physician, who initially encouraged vaccination for patients, cited two main reasons for this decision. The first was adverse reactions observed in elderly patients. Following the third dose, the doctor noticed a surge in health issues among residents of a senior care facility, raising concerns about potential vaccine-related side effects. The second was doubts about vaccine effectiveness. Despite receiving three doses, some patients still contracted COVID-19, leading the doctor to question the vaccine’s efficacy. The physician, now actively opposed to the vaccines, organizes regular educational sessions on vaccine side effects for the local community. Patients at the clinic express strong trust in the doctor, stating that they feel reassured by the clinic's stance.

Japan’s Ministry of Health, Labour and Welfare had previously published data on new COVID-19 cases based on vaccination history. A report from August 2022 showed that individuals vaccinated twice were the largest group among new cases across several age categories. However, data releases were discontinued after this report. Experts and citizens alike are urging the government to provide transparent data on both the benefits and risks of vaccinations.

Oishi’s commentary is available on YouTube and CBC Radio’s "Daijiro Now On Share". Additionally, his reports and analysis can be found on the official X (formerly Twitter) account. On January 26, Oishi will present a live emergency commentary on the Gifu gubernatorial election, highlighting its potential implications for Japan. Stay tuned for this special report.

Source: CBCニュース【CBCテレビ公式】

News On Japan
POPULAR NEWS

A passenger car was captured speeding across the frame from left to right by a security camera just moments before a fatal crash in Iida City, Nagano Prefecture, that claimed the lives of four vocational school students.

A fire broke out on the evening of April 25th on an electronic billboard attached to the Yodobashi Camera commercial complex in front of JR Osaka Station, prompting a large emergency response. No injuries were reported.

Organic fluorine compounds known as PFAS—suspected to be harmful to human health—have been detected at concentrations exceeding the national provisional target in rivers and groundwater at 242 sites across 22 prefectures, according to a government survey.

The Japanese government will begin issuing blue tickets for bicycle traffic violations in April 2026, with fines including 5,000 yen for ignoring stop signs and up to 12,000 yen for riding while using a smartphone.

A 26-year-old woman was arrested in the early hours of April 24th in Kasuya Town, Fukuoka Prefecture, on suspicion of driving under the influence of alcohol. While admitting to the offense, she claimed, "I ate chocolate that contained alcohol."

MEDIA CHANNELS
         

MORE Sci-Tech NEWS

Kyoto University and its research team have revealed that several former employees of Daikin Industries developed lung diseases, potentially linked to exposure to PFAS (per- and polyfluoroalkyl substances), a group of chemical compounds used in industrial manufacturing.

Amazon held a product briefing for its security brand "Ring" in Fukuoka City on April 21st, aiming to boost recognition in Fukuoka Prefecture, where the population continues to grow.

Japanese astronaut Takuya Onishi has been appointed commander of the International Space Station (ISS), becoming the third Japanese to assume the role.

A new treatment for Parkinson's disease using iPS cells developed by Kyoto University has shown a certain level of effectiveness in clinical trials.

Concerns are mounting over the discovery of illegal radio signals believed to originate from "fake base stations" mimicking cell towers in Tokyo and Osaka, with experts warning of the risk of personal data theft and potential fraud.

Pelvic organ prolapse is a condition affecting a significant number of women over the age of 40, yet remains largely under-recognized. It occurs when organs in the pelvic region, such as the bladder or uterus, descend due to weakened support muscles, often as a result of childbirth or aging.

As the new school term begins, a concerning trend is emerging with whooping cough—caused by the Bordetella pertussis bacterium—spreading across Japan and posing a potentially life-threatening risk, especially to infants who may suffer severe complications or even death from persistent coughing fits.

A new treatment using iPS cells, known for their ability to transform into any type of cell in the body, is poised to become the first of its kind in the world. A venture from Osaka University has applied to the Ministry of Health, Labor and Welfare for approval to manufacture and market the innovative therapy.